Pharmacogenetics studies in STAR*D: Strengths, limitations, and results

Pharmacogenetics studies in STAR*D: Strengths, limitations, and results

10.1176/appi.ps.60.11.1446

Saved in:

Bibliographic Details
Main Authors:	Laje, G., Perlis, R.H., Rush, A.J., McMahon, F.J.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Review
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110446
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Retention and attrition among African Americans in the STAR*D study: What causes research volunteers to stay or stray?
by: Murphy, E.J., et al.
Published: (2014)

Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder
by: Cutler, J.A., et al.
Published: (2014)

Star-D: Lessons learned and future implications
by: Rush, A.J.
Published: (2014)

Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies
by: Uher, R., et al.
Published: (2014)

What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression
by: Gaynes, B.N., et al.
Published: (2014)

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: Results of the NIMH star*D trial
by: Friedman, E.S., et al.
Published: (2014)

STAR*D: Revising conventional wisdom
by: Rush, J.A., et al.
Published: (2014)

STAR*D: Revising conventional wisdom
by: Rush, J.A., et al.
Published: (2014)

Health impacts of caregiving for older adults with functional limitations: Results from the Singapore survey on informal caregiving
by: Chan, A., et al.
Published: (2014)

Income and attrition in the treatment of depression: A STAR*D report
by: Warden, D., et al.
Published: (2014)

Recursive subsetting to identify patients in the STAR*D: A method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care
by: Kuk, A.Y.C., et al.
Published: (2014)

Family history of depression and therapeutic outcome: Findings from STAR*D
by: Husain, M.M., et al.
Published: (2014)

Depression outcomes of Spanish- and english-speaking hispanic outpatients in STAR*D
by: Lesser, I., et al.
Published: (2014)

Pharmacogenetics approach to therapeutics
by: Koo, S.H., et al.
Published: (2011)

One Coin in Three Fountains: The Educational Role of Church, State and Family
by: McMahon, James J.
Published: (1957)

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes
by: Davis, L.L., et al.
Published: (2014)

The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: A STAR*D report
by: Haley, C.L., et al.
Published: (2014)

Clinical pharmacology and pharmacogenetics of gemcitabine
by: Wong, A., et al.
Published: (2014)

Pharmacogenetics: The molecular genetics of CYP2D6 dependent drug metabolism
by: Wong, J.Y.Y., et al.
Published: (2016)

PHARMACOGENETICS OF MONOCARBOXYLATE TRANSPORTERS
by: LEAN CHOO BEE
Published: (2012)

Short-period binary stars : observations, analyses, and results
Published: (2017)

Pharmacogenetics of the human MDR1 multidrug transporter
by: Lee, C.G., et al.
Published: (2013)

Genetic modulation of oxytocin sensitivity: A pharmacogenetic approach
by: Chen F.S., et al.
Published: (2020)

M. Evelina Galang (ed.), Screaming Monkeys
by: McMahon, Jennifer M.
Published: (2012)

Images of America in Paz Marquez Benitez
by: McMahon, Jennifer M.
Published: (2012)

Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics
by: Soong, R., et al.
Published: (2014)

PharmGED: Pharmacogenetic effect database
by: Xie, B., et al.
Published: (2014)

Systemic therapies for pancreatic cancer - the role of pharmacogenetics
by: Soo, R.A., et al.
Published: (2014)

Pharmacogenetics: Role in modifying drug dosage regimens
by: Mah, J.T.L., et al.
Published: (2014)

PharmGED: Pharmacogenetic effect database
by: Zheng, C.J., et al.
Published: (2014)

Challenges and pitfalls in the introduction of pharmacogenetics for cancer
by: Loh, M., et al.
Published: (2014)

HEALTH ECONOMICS OF PHARMACOGENETIC TESTING
by: DONG DI
Published: (2015)

Clinical pharmacogenetics and potential application in personalized medicine
by: Zhou, S.-F., et al.
Published: (2014)

Results on memory-limited U-shaped learning
by: Carlucci, L., et al.
Published: (2013)

Pharmacogenetics and the prevention of mother-to-child transmission of HIV
by: Cressey T.R., et al.
Published: (2014)

Pharmacogenetics and the prevention of mother-to-child transmission of HIV
by: Tim R. Cressey, et al.
Published: (2018)

EPIC STAR: a reliable and efficient approach for phonon- and impurity-limited charge transport calculations
by: Deng, T., et al.
Published: (2021)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
by: Sessa F.
Published: (2023)

Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder
by: Perlis, R.H., et al.
Published: (2014)

Pharmacogenetics and its relevance to clinical practice
by: Sutiman, N., et al.
Published: (2016)